Prevalence of FMRI Expansions in Movement Disorders
FMRI 扩展在运动障碍中的患病率
基本信息
- 批准号:7413272
- 负责人:
- 金额:$ 17.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-08-08 至 2011-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcademyAgeAge of OnsetAllelesAmericanAreaAtaxiaAwardBiochemistryBiometryCGG repeatCGG repeat expansionCerebellar AtaxiaClinicClinical ResearchClinical SciencesColoradoCross-Sectional StudiesDataDevelopmentDiagnosisDiagnosticDiseaseDoctor of PhilosophyDyskinetic syndromeElderlyEpidemiologic StudiesEpidemiologyEthnic OriginEtiologyFMR1FMR1 GeneFMR1 PremutationFMR1 repeat expansionFXTASFellowshipFragile X SyndromeFrequenciesGait abnormalityGeneral PopulationGenesGenetic screening methodGenotypeGoalsGray unit of radiation doseImpaired cognitionIndividualInheritedIntention TremorLaboratory ResearchLengthLogistic RegressionsMeasuresMental RetardationMentored Clinical Oncology AwardMentored Clinical Scientist AwardMentored Patient-Oriented Research Career Development AwardMentorsModelingMorbidity - disease rateMovement DisordersNeurologicNeurologyOutcomeParkinsonian DisordersPatientsPenetrancePhenotypePolymerase Chain ReactionPopulationPopulation ControlPrevalencePrincipal InvestigatorProgram DevelopmentPublic HealthRaceRainRangeRecording of previous eventsRecruitment ActivityResearchResearch PersonnelResearch TrainingResidenciesSourceStandards of Weights and MeasuresSubgroupTraining ProgramsTremorTrinucleotide RepeatsUniversitiesWomanWorkage relatedaging populationbasedisabilitygenetic risk factorimprovedmalemenmortalitymultidisciplinarynervous system disordernovelpatient oriented researchprofessorprogramssizeskills
项目摘要
Dr. Deborah Ann Hall is applying for a mentored patient-oriented research (K23) award in the area of
movement disorders. This proposal describes a research and training program for the development of a
clinician-investigator in neurology. The principal investigator, Dr. Hall, has completed neurology residency
raining and a movement disorders fellowship. She received a competitive clinical research fellowship from
the American Academy of Neurology and is pursuing a Ph.D. in Clinical Science. The candidate's immediate
goals are to continue research in the fragile X-associated tremor/ataxia syndrome, by directly applying her
newly acquired epidemiologic and biostatistics skills in the proposed project. Her long term goals are to
study the genetic risk factors, neuroepidemiology, and treatment of ataxia, including sporadic ataxia.
During the award period, Dr. Hall will be based in the Department of Neurology at the University of Colorado
(UCDHSC). UCDHSC has an extensive track record for supporting and developing clinician-investigators.
The Ph.D. in Clinical Sciences program at UCDHSC facilitates mentored multidisciplinary clinical research.
The candidate will carry out her research with Professors Tim Byers MD (Epidemiology), Maureen Leehey
MD (Neurology), Gary Zerbe PhD (Biostatistics), and Paul Hagerman MD PhD (Biological Chemistry).
Dr. Hall's research program is to determine the prevalence of repeat expansions in the FMR1 (fragile X
mental retardation) gene in subjects with tremor, ataxia, and/or parkinsonism. Dr. Hall will do a cross-
sectional study by recruiting subjects in her clinics with the three phenotypes and performing PCR of the
FMR1 gene. All subjects eligible will be recruited and the genetic testing will be done in a research
laboratory. The primary outcomes to be measured are the prevalence of repeat expansions in the three
groups combined and each phenotypic subgroup. The age of onset, age of diagnosis of neurological signs,
and correlations between trinucleotide repeat size and phenotype are also outcomes to be measured.
Linear and logistic regression models will be used and covariates including race and ethnicity will be studied.
Relevance: This study is important because it may define genetic risk factors for various abnormal
movements, such as tremor. This will result in improved diagnosis and potentially treatment of individuals
with progressive neurological diseases. These illnesses represent an important public health problem as
they cause morbidity and mortality in our aging population.
黛博拉·安·霍尔博士正在申请一项指导性的以病人为导向的研究(K23)奖,该奖项在以下领域:
运动障碍本提案描述了一项研究和培训方案,
神经病学临床研究员。首席研究员霍尔博士已完成神经病学住院医师培训
下雨和运动障碍奖学金。她获得了竞争性的临床研究奖学金,
美国神经病学学会,正在攻读博士学位。临床科学。候选人的直接
我们的目标是继续研究脆性X相关震颤/共济失调综合征,通过直接应用她的
在拟议项目中新获得的流行病学和生物统计学技能。长期目标是
研究共济失调的遗传危险因素、神经流行病学和治疗,包括散发性共济失调。
在获奖期间,霍尔博士将在科罗拉多大学神经病学系工作
(UCDHSC)。UCDHSC在支持和发展临床研究人员方面有着广泛的记录。
的博士在临床科学计划在UCDHSC促进指导多学科临床研究。
候选人将与Tim Byers医学博士(流行病学),Maureen Leehey教授一起开展研究
医学博士(神经病学)、加里泽贝博士(生物统计学)和保罗哈格曼医学博士(生物化学)。
博士Hall的研究计划是确定FMR 1(脆性X染色体)中重复扩增的普遍性。
精神发育迟滞)基因。霍尔医生会做交叉检查
通过在她的诊所招募具有三种表型的受试者并进行PCR,
FMR 1基因。将招募所有符合条件的受试者,并在研究中进行基因检测
实验室要衡量的主要结果是三个重复扩张的患病率,
组组合和每个表型亚组。发病年龄、诊断神经系统体征的年龄,
三核苷酸重复序列大小和表型之间的相关性也是要测量的结果。
将使用线性和逻辑回归模型,并研究包括人种和种族在内的协变量。
相关性:这项研究很重要,因为它可以定义各种异常的遗传风险因素。
运动,如震颤。这将导致改善诊断和潜在的个人治疗
患有进行性神经系统疾病这些疾病是一个重要的公共卫生问题,
这些疾病会令本港人口老化,引致发病和死亡。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DEBORAH A HALL其他文献
DEBORAH A HALL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DEBORAH A HALL', 18)}}的其他基金
Racial Disparities in Parkinson Disease- Clinical Phenotype, Management and Genetics
帕金森病的种族差异 - 临床表型、治疗和遗传学
- 批准号:
10346329 - 财政年份:2022
- 资助金额:
$ 17.33万 - 项目类别:
Racial Disparities in Parkinson Disease- Clinical Phenotype, Management and Genetics
帕金森病的种族差异 - 临床表型、治疗和遗传学
- 批准号:
10586033 - 财政年份:2022
- 资助金额:
$ 17.33万 - 项目类别:
Adult Neurological Phenotypes of Fragile X Gray Zone Expansion
脆弱 X 灰区扩展的成人神经表型
- 批准号:
8480195 - 财政年份:2013
- 资助金额:
$ 17.33万 - 项目类别:
Adult Neurological Phenotypes of Fragile X Gray Zone Expansion
脆弱 X 灰区扩展的成人神经表型
- 批准号:
9012853 - 财政年份:2013
- 资助金额:
$ 17.33万 - 项目类别:
Adult Neurological Phenotypes of Fragile X Gray Zone Expansion
脆弱 X 灰区扩展的成人神经表型
- 批准号:
8814284 - 财政年份:2013
- 资助金额:
$ 17.33万 - 项目类别:
PREVALENCE OF FMR1 EXPANSIONS IN MOVEMENT DISORDERS
运动障碍中 FMR1 扩展的患病率
- 批准号:
7719520 - 财政年份:2008
- 资助金额:
$ 17.33万 - 项目类别:
PREVALENCE OF FMR1 EXPANSIONS IN MOVEMENT DISORDERS
运动障碍中 FMR1 扩展的患病率
- 批准号:
7604470 - 财政年份:2007
- 资助金额:
$ 17.33万 - 项目类别:
Prevalence of FMRI Expansions in Movement Disorders
FMRI 扩展在运动障碍中的患病率
- 批准号:
7804478 - 财政年份:2006
- 资助金额:
$ 17.33万 - 项目类别:
Prevalence of FMRI Expansions in Movement Disorders
FMRI 扩展在运动障碍中的患病率
- 批准号:
7103035 - 财政年份:2006
- 资助金额:
$ 17.33万 - 项目类别:
Prevalence of FMRI Expansions in Movement Disorders
FMRI 扩展在运动障碍中的患病率
- 批准号:
7893468 - 财政年份:2006
- 资助金额:
$ 17.33万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Determining the mechanism of action of cis-acting modifiers on the age of onset of Huntington Disease
确定顺式作用修饰剂对亨廷顿病发病年龄的作用机制
- 批准号:
417256 - 财政年份:2019
- 资助金额:
$ 17.33万 - 项目类别:
Studentship Programs
Effect of age of onset of contraception use on brain functioning.
避孕开始年龄对大脑功能的影响。
- 批准号:
511267-2017 - 财政年份:2017
- 资助金额:
$ 17.33万 - 项目类别:
University Undergraduate Student Research Awards
Non-random occurrence and early age of onset of diverse lymphoid cancers in families supports the existence of genetic risk factors for multiple lymphoid cancers.
家族中多种淋巴癌的非随机发生和发病年龄较早,支持多种淋巴癌存在遗传危险因素。
- 批准号:
347105 - 财政年份:2016
- 资助金额:
$ 17.33万 - 项目类别:
Polish-German Child Bilingualism: The Role of Age of Onset for Long-Term Achievement
波兰-德国儿童双语:发病年龄对长期成就的作用
- 批准号:
277135691 - 财政年份:2015
- 资助金额:
$ 17.33万 - 项目类别:
Research Grants
Bioinformatics strategies to relate age of onset with gene-gene interaction
将发病年龄与基因间相互作用联系起来的生物信息学策略
- 批准号:
9097781 - 财政年份:2015
- 资助金额:
$ 17.33万 - 项目类别:
Early Age-of-Onset AD: Clinical Heterogeneity and Network Degeneration
早期 AD 发病年龄:临床异质性和网络退化
- 批准号:
9212684 - 财政年份:2014
- 资助金额:
$ 17.33万 - 项目类别:
Early Age-of-Onset AD: Clinical Heterogeneity and Network Degeneration
早期 AD 发病年龄:临床异质性和网络退化
- 批准号:
8696557 - 财政年份:2014
- 资助金额:
$ 17.33万 - 项目类别:
Effects of delaying age of onset of binge drinking on adolescent brain development: A proposal to add neuroimaing measures to the CO-Venture Trial.
延迟酗酒的发病年龄对青少年大脑发育的影响:在 CO-Venture 试验中添加神经影像测量的建议。
- 批准号:
267251 - 财政年份:2012
- 资助金额:
$ 17.33万 - 项目类别:
Operating Grants
Stress Effects on Alcohol Consumption: Age of onset and genes in heavy drinkers
压力对饮酒的影响:酗酒者的发病年龄和基因
- 批准号:
8606722 - 财政年份:2012
- 资助金额:
$ 17.33万 - 项目类别:
Marijuana: Neurobiologic Correlates of Age of Onset
大麻:发病年龄的神经生物学相关性
- 批准号:
8644793 - 财政年份:2012
- 资助金额:
$ 17.33万 - 项目类别: